Prolonged Survival on PARP Inhibitor Therapy In a Patient With Stage IV Non-small Cell Lung Cancer: A Case Report. acmcr. 2019;3(2):59-61. Accessed September 11, 2026. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22121